Nuclear Medicine, IRCCS San Raffaele Hospital, Milan, Italy.
School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Cancer Imaging. 2024 Nov 26;24(1):162. doi: 10.1186/s40644-024-00807-3.
Although many well-known factors affect the maximum standardized uptake value (SUVmax), it remains the most requested and used parameter, especially among clinicians, despite other parameters, such as the standardized uptake value corrected for lean body mass and the metabolic tumor volume, being proven to be less sensitive to the same factors, more robust, and eventually more informative. This study intends to provide robust evidence regarding the diagnostic and prognostic value of SUVmax in a large cohort of subjects with suspected malignant lung nodules imaged by [F]FDG PET/CT.
We performed a retrospective analysis of patients with suspected/confirmed primary lung tumours undergoing [18F]FDG PET/CT. The sample size was 567 patients. Demographics, imaging, surgical, histological, and follow-up data were collected. SUVmax was analysed according to histology, stage, scanner, and outcome. The impact on measured values of different reconstruction protocols was assessed. All potential predictors of patients' outcome were assessed.
91% cases were primary lung tumours. Lung benign nodules or metastases accounted for 5% and 4% of cases. Most patients presented with adenocarcinoma (70%) and stage I disease (51%); 144 patients relapsed and 55 died. SUVmax failed to effectively differentiate benign lesions from primary tumours or metastases. Stage I patients presented lower SUVmax. SUVmax significantly correlated with patient weight, injected [F]FDG activity, and lesion size and differed between reconstructions' protocols. Survival analyses revealed no independent prognostic significance for SUVmax in progression-free after adjusting for other variables. SUVmax correlated with overall survival, disease stage and tumour histotype.
Our study confirms that SUVmax, though widely employed, present relevant limitations in discriminating between benign lesion and lung cancer, in classifying cancer histotypes, and in predicting patient outcomes independently. Known influencing factors significantly impact on numerical values, thus SUV values should be regarded with caution in clinical practice.
尽管有许多众所周知的因素会影响最大标准化摄取值(SUVmax),但它仍然是最受请求和使用的参数,尤其是在临床医生中,尽管其他参数,如瘦体重校正标准化摄取值和代谢肿瘤体积,已被证明对相同因素的敏感性较低、更稳健,最终更具信息量。本研究旨在为 [F]FDG PET/CT 成像的疑似恶性肺结节的大样本患者中 SUVmax 的诊断和预后价值提供有力证据。
我们对疑似/确诊原发性肺癌患者进行了回顾性分析,这些患者接受了 [18F]FDG PET/CT 检查。样本量为 567 例。收集了患者的人口统计学、影像学、手术、组织学和随访数据。根据组织学、分期、扫描仪和结果分析了 SUVmax。评估了不同重建方案对测量值的影响。评估了所有可能影响患者预后的预测因素。
91%的病例为原发性肺癌,肺良性结节或转移瘤分别占 5%和 4%。大多数患者为腺癌(70%)和 I 期疾病(51%);144 例患者复发,55 例患者死亡。SUVmax 无法有效区分良性病变与原发性肿瘤或转移瘤。I 期患者 SUVmax 较低。SUVmax 与患者体重、注射 [F]FDG 活性、病变大小显著相关,并且在不同重建方案之间存在差异。在调整其他变量后,生存分析显示 SUVmax 对无进展生存期无独立的预后意义。SUVmax 与总生存期、疾病分期和肿瘤组织学类型相关。
本研究证实,SUVmax 虽然广泛应用,但在区分良性病变和肺癌、分类癌症组织学类型以及独立预测患者预后方面存在相关局限性。已知的影响因素对数值有显著影响,因此在临床实践中应谨慎看待 SUV 值。